FDA Device Intelligence
HomeRoche Diagnostics GmbH › Elecsys Testosterone II

Elecsys Testosterone II

Roche Diagnostics GmbH · Model 08946370190 · UDI-DI 07613336170571

CDZ Prescription
1
510(k) clearances
163
Adverse events
19
Recalls
57
Facilities

Description

Testosterone G2 Elecsys E2G 300 V2

Recalls

DateFirmReason
2026-06-12Tosoh Bioscience IncThe Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer (AIA) which could cause falsely elevated
2025-11-03GET TESTED INTERNATIONAL ABDistribution without premarket approval/clearance.
2025-05-05Beckman Coulter, Inc.Inadequate preventative maintenance (PM) performed on the scales of the RPL5 fill line, led to splashing (cross-contamination) between the wells of testosterone reagent packs lot 5
2024-12-03Qualigen IncThree lots of the FastPacks kitted into the FastPack SHBG Complete Kits were labeled with the incorrect expiration date. The following is a listing of affected lots: Lot Number: 24
2024-07-05DRG International, Inc.Invalid Controls. The Low Control is out of range; too high which causes invalid runs that would result in repeating the runs and delays for reporting results to patients.
2022-10-25Siemens Healthcare Diagnostics, Inc.Confirmed an average positive bias of 40% for testosterone concentrations of approximately 660 ng/dL (22.9 nmol/L) and above with the IMMULITE/IMMULITE 1000 Total Testosterone Assa
2019-11-06Qualigen IncThe chemiluminescent immunoassay has been noted to have higher than expected results which may result in inaccurate quantitative determinations of Sex Hormone Binding Globulin in h
2019-05-21DRG Instruments GmbHSalivary assay may observe a higher percentage of samples with 0 pg/ml testosterone or results which are too low. Saliva samples in the low measuring range of the kit(< 50 pg/ml) w
2018-11-30Tosoh Bioscience Inc
2018-03-21Siemens Healthcare Diagnostics, Inc.The diluent may have an incomplete slit on the septum in the cap of the vial. A diluent cap with a defective septum has the potential to cause erroneously elevated results if a sa

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.